MedCity News
FEBRUARY 11, 2025
The Anthos Therapeutics acquisition represents a homecoming for its drug abelacimab, which originated in Novartiss labs. The antibody offers the potential to prevent blood clots without the bleeding risks associated with currently available anticoagulants. The post Novartiss $925M Anthos Acquisition Brings Back Cardio Drug That Stops Blood Clots appeared first on MedCity News.
PharmaVoice
FEBRUARY 11, 2025
What will it take for a clinical-stage biotech to break into the cardio space? One CEO thinks he has the answer.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
FEBRUARY 11, 2025
Novartis has agreed to acquire Anthos Therapeutics, Inc., and will gain rights to a potential first-in-class biologic. Anthos has been developing the monoclonal antibody abelacimab as a treatment to prevent stroke and systemic embolism in individuals with atrial fibrillation, under a license from Novartis. The therapy is designed to induce effective haemostasis-sparing anticoagulation through Factor XI inhibition, preventing the activated form (Factor XIa) being generated.
Scott Burrows
FEBRUARY 11, 2025
When you think of the qualities that make an elite athlete, you might immediately think of strength, speed, and skill. But theres something else that plays a crucial role in both sports and business: mindset. At 19, I was living my dream as a wide receiver for Florida State University and a champion kickboxer. But then, in the blink of an eye, I found myself paralyzed from the chest down after a car accident.
Advertiser: ZoomInfo
AI adoption is reshaping sales and marketing. But is it delivering real results? We surveyed 1,000+ GTM professionals to find out. The data is clear: AI users report 47% higher productivity and an average of 12 hours saved per week. But leaders say mainstream AI tools still fall short on accuracy and business impact. Download the full report today to see how AI is being used — and where go-to-market professionals think there are gaps and opportunities.
PharmaTech
FEBRUARY 11, 2025
Feb. 11, 2025 marks the 10th anniversary of the International Day of Women and Girls in Science.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
pharmaphorum
FEBRUARY 11, 2025
Novartis has agreed to buy Anthos from private equity firm Blackstone for $3.1 billion, taking Factor XI inhibitor abelacimab back in-house.
Pharmaceutical Technology
FEBRUARY 11, 2025
Given the number of comorbidities associated with obesity, the market's growth will impact the entire cardiometabolic disease space.
PharmaTimes
FEBRUARY 11, 2025
New immunotherapy offers hope for recurrent cervical cancer
Pharmaceutical Technology
FEBRUARY 11, 2025
The World Health Organization and St Jude Children's Research Hospital have kicked off a programme to distribute cancer medicines to LMICs.
Speaker: Jesse Hunter and Brynn Chadwick
Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.
pharmaphorum
FEBRUARY 11, 2025
It's been 10 years since Roche bought InterMune for $8.3bn on the promise of its pulmonary fibrosis drug Esbriet.
PharmaTimes
FEBRUARY 11, 2025
Treatment expands options for HER2-negative metastatic breast cancer
pharmaphorum
FEBRUARY 11, 2025
It's been 10 years since Roche bought InterMune for $8.3bn on the promise of its pulmonary fibrosis drug Esbriet.
PharmaTech
FEBRUARY 11, 2025
Christian Morello, vice president and head of the Bioconjugates Business Unit at Lonza, discusses the challenges and unmet needs in bringing ADCs to market.
Advertiser: ZoomInfo
ZoomInfo customers aren’t just selling — they’re winning. Revenue teams using our Go-To-Market Intelligence platform grew pipeline by 32%, increased deal sizes by 40%, and booked 55% more meetings. Download this report to see what 11,000+ customers say about our Go-To-Market Intelligence platform and how it impacts their bottom line. The data speaks for itself!
Pharmaceutical Technology
FEBRUARY 11, 2025
The UK announced the funding at the AI Action Summit in Paris where it abstained from signing a declaration on an inclusive approach to AI.
Pharmaceutical Commerce
FEBRUARY 11, 2025
Leaders with top third-party logistics providers discuss the evolving landscape for the sector in 2025and the new strides made in their quest to help transform the pharma supply chain.
Pharmaceutical Technology
FEBRUARY 11, 2025
Grace has announced the initial closing of a financing round, securing almost $15m, for funding pre-commercial development of GTx-104.
PharmaTech
FEBRUARY 11, 2025
In a lead up to The International Day of Women and Girls in Science, Pharmaceutical Technology takes a look at the unique perspective women bring to the use of artificial intelligence in the pharmaceutical industry.
Speaker: Kevin Burke
AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.
Pharmaceutical Commerce
FEBRUARY 11, 2025
Business strategies and top news in the biotech / biopharma industry, including market access, supply chain distribution and more.
Pharmaceutical Technology
FEBRUARY 11, 2025
Eli Lilly is paying up to $630m for a Phase I MASH candidate from OliX Pharmaceuticals, diversifying its pipeline with an RNA-based asset.
Pharmaceutical Commerce
FEBRUARY 11, 2025
In the second part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Jim Shehan, chair of the FDA regulatory practice at Lowenstein Sandler, discusses some of the other specific regulatory updates that drug developers be closely monitoring in the current landscape.
Pharmaceutical Technology
FEBRUARY 11, 2025
Bio-Thera Solutions has signed an exclusive licence and commercialisation agreement with Intas Pharmaceuticals for BAT2506 in the US.
Advertiser: ZoomInfo
Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.
pharmaphorum
FEBRUARY 11, 2025
Merck KGaA has acknowledged that it is in talks to buy US biotech SpringWorks, but cautioned there is no guarantee a deal will be forthcoming
Pharmacy Times
FEBRUARY 11, 2025
Pharmacists can recommend vitamin D supplements and vitamin D-rich foods to support healthy pregnancy outcomes.
pharmaphorum
FEBRUARY 11, 2025
Boehringer Ingelheim has a second positive trial under its belt for nerandomilast in pulmonary fibrosis, setting up regulatory filings
Pharmaceutical Commerce
FEBRUARY 11, 2025
Trade & Channel Strategies conference explores the frontline issues related to strategy, distribution, and reimbursementwhile digging into creative solutions to solve them.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
PharmaTech
FEBRUARY 11, 2025
The company says it is the pharmaceutical markets first wet granulator with an integrated, truly continuous dryer.
ALULA
FEBRUARY 11, 2025
Explore how the Philadelphia Eagles' championship journey reveals authentic leadership lessons for business, from purposeful vision to building genuine trust.
Pharmaceutical Technology
FEBRUARY 11, 2025
Sponsors need to try and solve the issue of inadequate enrolment by having better site relationships.
Expert insights. Personalized for you.
176 
Let's personalize your content